|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,408.00 JPY | -1.90% |
|
-6.26% | +11.85% |
| 07-30 | Keros Therapeutics to Receive $20 Million Development Milestone Payment From Takeda | DJ |
| 07-30 | Takeda Pharmaceutical Company Limited, Q1 2027 Earnings Call, Jul 30, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Other Pharmaceuticals | -1.90% | -6.26% | +11.85% | +28.18% | +48.08% | 55.24B |  |  | |
- Stock Market
- Stocks
- 4502 Stock
- Charts Takeda Pharmaceutical Company Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
